Neurotech International Ltd
ASX:NTI
Neurotech International Ltd
ASX:NTI
Price:
0.078 AUD
4%
Market Closed
Updated:
May 16, 2024
Section:
Relative Value
The Relative Value of one
NTI
stock under the Base Case scenario is
0.006
AUD.
Compared to the current market price of 0.078 AUD,
Neurotech International Ltd
is
Overvalued by 92%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
NTI
Relative Value
Base Case
0.006
AUD
Overvaluation 92%
Valuation Multiples
Multiples Across Competitors
NTI Competitors Multiples
Neurotech International Ltd Competitors
Neurotech International Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| AU |
|
Neurotech International Ltd
ASX:NTI
|
79.4m AUD | 62.1 | -15.9 | -15 | -15 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
182.2B USD | 4.5 | 32.4 | 19.1 | 28.5 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
140.8B USD | 19.2 | 70.9 | 58.2 | 73 | |
| US |
|
Stryker Corp
NYSE:SYK
|
127.3B USD | 6.1 | 37.9 | 24.6 | 30.2 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
113.8B USD | 3.5 | 27.1 | 14.3 | 20.3 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
109.6B USD | 7.5 | 62.1 | 31.2 | 46.1 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
68.2B USD | 3.5 | 55.9 | 18.7 | 39.5 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
60.6B EUR | 2.8 | 39.9 | 19.1 | 32.1 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
54.4B USD | 8.9 | 38.5 | 28 | 30.3 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
378.2B CNY | 10.5 | 31.1 | 28.6 | 28.6 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
52.2B USD | 13.7 | 81.6 | 61 | 79.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
